Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
12.50
-0.49 (-3.77%)
Jul 18, 2024, 3:17 PM EDT - Market closed

Eiger BioPharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2011
Revenue
15.7715.7713.4812.1400
Upgrade
Revenue Growth (YoY)
16.98%16.98%11.05%---
Upgrade
Cost of Revenue
0.020.021.840.7500
Upgrade
Gross Profit
15.7515.7511.6511.400
Upgrade
Selling, General & Admin
25.225.229.1123.920.5617.11
Upgrade
Research & Development
62.3362.3375.2864.4441.5951.79
Upgrade
Operating Expenses
87.5487.54104.3988.3462.1568.9
Upgrade
Operating Income
-71.79-71.79-92.74-76.94-62.15-68.9
Upgrade
Interest Expense / Income
5.475.474.133.563.593.41
Upgrade
Other Expense / Income
-2.3-2.3-0.12-46.65-0.69-2.06
Upgrade
Pretax Income
-74.96-74.96-96.75-33.85-65.05-70.25
Upgrade
Income Tax
0.010.010.020.0600
Upgrade
Net Income
-74.96-74.96-96.78-33.92-65.05-70.25
Upgrade
Shares Outstanding (Basic)
111111
Upgrade
Shares Outstanding (Diluted)
111111
Upgrade
Shares Change
6.39%6.39%22.64%20.61%23.51%67.12%
Upgrade
EPS (Basic)
-50.78-50.78-69.74-30.00-69.30-92.40
Upgrade
EPS (Diluted)
-50.78-50.78-69.74-30.00-69.30-92.40
Upgrade
Free Cash Flow
-74.78-74.78-83.35-71.29-63.44-64.09
Upgrade
Free Cash Flow Per Share
-50.66-50.66-60.07-63.00-67.63-84.38
Upgrade
Gross Margin
99.85%99.85%86.38%93.86%--
Upgrade
Operating Margin
-455.12%-455.12%-687.78%-633.66%--
Upgrade
Profit Margin
-475.26%-475.26%-717.71%-279.34%--
Upgrade
Free Cash Flow Margin
-474.11%-474.11%-618.14%-587.10%--
Upgrade
EBITDA
-68.74-68.74-91.78-29.5-60.81-66.36
Upgrade
EBITDA Margin
-435.81%-435.81%-680.65%-242.92%--
Upgrade
Depreciation & Amortization
0.750.750.840.80.650.49
Upgrade
EBIT
-69.49-69.49-92.62-30.29-61.46-66.85
Upgrade
EBIT Margin
-440.57%-440.57%-686.90%-249.50%--
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).